Comparison of Pivotal Medial Polyethylene Versus Ultra-congruent in Total Knee Arthroplasty

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorUniversity Hospital, Clermont-Ferrand

About this trial

The aim of this study is to compare the forgotten joint score for the medial pivot polyethylene and ultra-congruent polyethylene which are used in total prosthetic replacement of the knee

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subjects 18 to 90 years of age, eligible for a primary total knee replacement for gonarthrosis

Competent subjects able to give informed consent to participate in the research

Affiliation to the social security system

Disqualifiers

Infection history of the knee to be replaced

Deformity greater than 15 degrees

Any surgical and/or anesthetic contraindication, or any condition deemed by the investigator to be incompatible with the research.

Any contraindication mentioned in the instructions for use of the medical device

Trial design

Design model

Parallel

Treatments tested in this trial

  • total knee arthroplasty with medial pivot polyethylene

    Device

    total knee arthroplasty with medial pivot polyethylene

  • total knee arthroplasty with ultra-congruent polyethylene

    Device

    total knee arthroplasty with ultra-congruent polyethylene

Treatment groups

90 Participants
are divided into 2 treatment groups
Group A: medial pivot polyethyleneActive comparator 1 intervention
Group B: ultra-congruent polyethyleneActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

evaluation of the forgotten joint score (FJS12)

Forgotten knee score at 6 weeks (FJS-12, evaluated out of 100), which allows the analysis of quality of life specifically in relation to knee pathologies

Time frame
Day 45
2

evaluation of the forgotten joint score (FJS12)

Forgotten knee score at 6 weeks (FJS-12, evaluated out of 100), which allows the analysis of quality of life specifically in relation to knee pathologies

Time frame
Month 12

Secondary outcomes

1

knee joint mobility

Measurement of mobility in degrees (scale from 0 to 10)

Time frame
Day -1
2

knee joint mobility

Measurement of mobility in degrees (scale from 0 to 10)

Time frame
Day 45
3

knee joint mobility

Measurement of mobility in degrees (scale from 0 to 10)

Time frame
month 12
4

pain assessment

assessment with a numeric pain rating scale ranging from 0 (none) to 10 (severe pain)

Time frame
Day -1

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.